Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administra
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
11:01am, Friday, 10'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Medical Stocks Lagging United Therapeutics (UTHR) This Year?
10:46am, Thursday, 09'th Jan 2025
Here is how United Therapeutics (UTHR) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
10:46am, Thursday, 09'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UTHR vs. STVN: Which Stock Is the Better Value Option?
12:55pm, Wednesday, 08'th Jan 2025
Investors interested in stocks from the Medical - Drugs sector have probably already heard of United Therapeutics (UTHR) and Stevanato Group (STVN). But which of these two stocks is more attractive to
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07:00am, Monday, 06'th Jan 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Dr. Martine Rothblatt, Chairperso
The Zen Ten - My Top Picks For 2025
04:25pm, Sunday, 29'th Dec 2024
I've been publishing the Zen Ten list since 2008, consistently beating the market by an average of 9.1% per year since 2000. My methodology involves a rigorous three-step screening process using Zacks
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
10:51am, Wednesday, 25'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term
10:46am, Monday, 23'rd Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is United Therapeutics (UTHR) Up 1.1% Since Last Earnings Report?
12:36pm, Friday, 29'th Nov 2024
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock?
United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy
06:27pm, Friday, 15'th Nov 2024
UTHR's competitive advantages, including high returns on capital and successfully recycling of profits, support a bullish outlook. United Therapeutics' Q3 FY '24 earnings showed strong growth across m
United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom
07:00am, Friday, 15'th Nov 2024
Despite legal challenges and exclusivity risks, United Therapeutics is a leader in PAH treatments, with Tyvaso being the primary revenue driver. UTHR is innovating in organ transplantation and bioengi
United Therapeutics: One To Believe In Despite Competitive Threats
05:16pm, Thursday, 14'th Nov 2024
United Therapeutics Corporation's stock has surged over 300% since my 2020 “Buy” rating, driven by strong sales of Tyvaso DPI and other PAH treatments. Despite facing generic competition, United h
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
04:30pm, Tuesday, 05'th Nov 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice P
United Therapeutics (UTHR) is a Top-Ranked Growth Stock: Should You Buy?
10:45am, Tuesday, 05'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
